01 1Patheon Italia S.p.A
01 1oritavancin
01 1U.S.A
NDC Package Code : 68225-051
Start Marketing Date : 2014-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (400mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
65
PharmaCompass offers a list of Oritavancin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oritavancin manufacturer or Oritavancin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oritavancin manufacturer or Oritavancin supplier.
PharmaCompass also assists you with knowing the Oritavancin API Price utilized in the formulation of products. Oritavancin API Price is not always fixed or binding as the Oritavancin Price is obtained through a variety of data sources. The Oritavancin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oritavancin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oritavancin, including repackagers and relabelers. The FDA regulates Oritavancin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oritavancin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oritavancin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oritavancin supplier is an individual or a company that provides Oritavancin active pharmaceutical ingredient (API) or Oritavancin finished formulations upon request. The Oritavancin suppliers may include Oritavancin API manufacturers, exporters, distributors and traders.
click here to find a list of Oritavancin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oritavancin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oritavancin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oritavancin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oritavancin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oritavancin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oritavancin suppliers with NDC on PharmaCompass.
